Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Liquidia Corp | 1,041,667 | reported | 27 May 2026 | tx 65+6,336,483−1,245,153 |
| Axovant Sciences Ltd. | 255,000 | reported | 15 Apr 2019 | tx 2+405,000 |
| UNITED THERAPEUTICS Corp | 245,000 | reported | 15 Mar 2016 | tx 1043+4,913,962−5,287,366 |
| Axsome Therapeutics, Inc. | 57,510 | reported | 02 Sept 2025 | tx 57+432,290−334,148 |
| SANGAMO THERAPEUTICS, INC | 9,908 | reported | 07 Sept 2018 | tx 4+54,908 |
| Biodel Inc | 8,000 | reported | 24 Jun 2021 | tx 6+38,000 |
| Dova Pharmaceuticals, Inc. | 0 | reported | 12 Nov 2019 | tx 10+88,301−111,301 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | SALE | Liquidia Corp | 6,428 | 62.18 USD | 10b5-1 |
| 21 May 2026 | SALE | Liquidia Corp | 25,000 | 61.13 USD | 10b5-1 |
| 22 May 2026 | SALE | Liquidia Corp | 25,000 | 61.52 USD | 10b5-1 |
| 26 May 2026 | SALE | Liquidia Corp | 25,000 | 60.38 USD | 10b5-1 |
| 18 May 2026 | SALE | Liquidia Corp | 25,000 | 56.77 USD | 10b5-1 |
| 19 May 2026 | SALE | Liquidia Corp | 25,000 | 58.65 USD | 10b5-1 |
| 20 May 2026 | SALE | Liquidia Corp | 25,000 | 61.30 USD | 10b5-1 |
| 13 May 2026 | SALE | Liquidia Corp | 25,000 | 56.29 USD | 10b5-1 |
| 14 May 2026 | SALE | Liquidia Corp | 25,000 | 58.62 USD | 10b5-1 |
| 15 May 2026 | SALE | Liquidia Corp | 25,000 | 57.04 USD | 10b5-1 |
| 08 May 2026 | SALE | Liquidia Corp | 25,000 | 42.14 USD | 10b5-1 |
| 11 May 2026 | SALE | Liquidia Corp | 25,000 | 41.50 USD | 10b5-1 |
| 12 May 2026 | SALE | Liquidia Corp | 25,000 | 54.04 USD | 10b5-1 |
| 05 May 2026 | SALE | Liquidia Corp | 25,000 | 40.10 USD | 10b5-1 |
| 06 May 2026 | SALE | Liquidia Corp | 25,000 | 40.78 USD | 10b5-1 |
| 07 May 2026 | SALE | Liquidia Corp | 25,000 | 42.09 USD | 10b5-1 |
| 16 Jan 2026 | GRANT_AWARD | Liquidia Corp | 115,344 | 0.00 USD | |
| 16 Jan 2026 | GRANT_AWARD | Liquidia Corp | 173,016 | 0.00 USD | deriv |
| 12 Jan 2026 | SALE | Liquidia Corp | 66,610 | 37.43 USD | |
| 09 Jan 2026 | EXERCISE | Liquidia Corp | 57,332 | — | |
| 09 Jan 2026 | EXERCISE | Liquidia Corp | 13,833 | — | |
| 09 Jan 2026 | EXERCISE | Liquidia Corp | 13,833 | 0.00 USD | deriv |
| 09 Jan 2026 | EXERCISE | Liquidia Corp | 57,332 | 0.00 USD | deriv |
| 13 Oct 2025 | SALE | Liquidia Corp | 20,261 | 23.41 USD | |
| 10 Oct 2025 | EXERCISE | Liquidia Corp | 13,834 | — |
3 purchases reported after at least 12 months of silence — most recent on 14 Dec 2023.